Clinical Trials at University of Washington
As of September 2026, 167 paid clinical trials are recruiting at University of Washington, located at 325 9TH AVE, SEATTLE, WA 98104-2420, phone (206) 744-4371 in Seattle, Washington. Active studies at this site cover conditions such as Acute Myeloid Leukemia, Breast Cancer and Colorectal Cancer. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Seattle
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
168 clinical trials at University of Washington
·Clear filters·A Study of Pasritamig With or Without JNJ-87189401 Versus Placebo for Late Line Metastatic Castration-resistant Prostate Cancer (mCRPC)
A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events
Pelacarsen Roll-over Extension Program
Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
ARTIST: Aortic Regurgitation Trial Investigating Surgery Versus Trilogy™
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
A Study to Learn About the Effects of the Combination of Elranatamab (PF-06863135) and Iberdomide in Patients With Relapsed or Refractory Multiple Myeloma (MagnetisMM-30)
Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's Disease
Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance
A Study to Test Whether BI 3032950 Helps People With Ulcerative Colitis
ATLAS (AltaValve) Pivotal Trial
RevCore for In Stent Thrombosis
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
EFS of the DUO System for Tricuspid Regurgitation
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Suprachoroidal Administration in Subjects With Metastases to the Choroid
A Clinical Study of YL205 in Patients With Advanced Solid Tumors
A Study to Evaluate the Safety and Effectiveness of the InnAVasc Arteriovenous Graft for Hemodialysis Access in Patients With End-Stage Renal Disease
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
A Study of NST-6179 in Subjects With Intestinal Failure-Associated Liver Disease (IFALD).
SMP-3124LP in Adults With Advanced Solid Tumors
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Anti-CD14 Treatment With IC14 in Hospitalized ARDS Patients
A Proof-of-Concept Study to Learn Whether Linvoseltamab Can Eliminate Abnormal Plasma Cells That May Lead to Multiple Myeloma in Adult Patients With High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
Use of CereGate Therapy for Freezing of Gait in PD
Development of a Quantifiable Ultrasound Biomarker for Hepatic Steatosis
Moda-flx Hemodialysis System™ Under Professional Care Settings by Trained Individuals and At Home by Participants
PRGN-2009 in Combination With Pembrolizumab in Patients With Recurrent or Metastatic Cervical Cancer
Post Marketing Study of MagnetOs Easypack Putty Standalone Compared to Demineralized Bone Matrix or Fibers Mixed With Autograft in Patients Undergoing Posterolateral Lumbar Fusion
A Study of KK2269 in Adult Participants With Solid Tumors
ViTAA Registry Pre- and Post-Operative Monitoring for Endovascular Aortic Aneurysm Repair and Serial Monitoring for AAA
Study of Student Flourishing
PRO and Wearable Data Insights From Individuals With R/R Multiple Myeloma
Real World Insights During Treatment for Relapsed/Refractory Multiple Myeloma with Isatuximab
Collaboration for Down Syndrome Progress (CDP)
Physical Activity Through Health Technology in Axial Spondyloarthritis
Common conditions studied in Seattle
- Acute Myeloid Leukemia (34 active studies)
- Breast Cancer (20 active studies)
- Colorectal Cancer (20 active studies)
- Ovarian Cancer (16 active studies)
- Multiple Myeloma (15 active studies)
- Prostate Cancer (14 active studies)
Leading research sponsors in Seattle
- University of Washington
- Fred Hutchinson Cancer Center
- National Cancer Institute (NCI)
- Seattle Children's Hospital
- AstraZeneca
Frequently asked questions
How many paid clinical trials are currently recruiting in Seattle?
There are approximately 1,287 recruiting clinical trials in Seattle, Washington listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Seattle pay participants?
Most recruiting trials in Seattle compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Seattle?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Seattle?
The most common conditions under active study in Seattle include Acute Myeloid Leukemia (34), Breast Cancer (20), Colorectal Cancer (20), Ovarian Cancer (16), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Seattle?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Seattle on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Seattle?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Seattle?
Recruiting research sites in Seattle include Seattle Children's Hospital, University of Washington, Fred Hutchinson Cancer Center, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Seattle right now?
The largest active categories in Seattle are Cancer & tumors (494), Neurology & pain (63), Diabetes & metabolic (60). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of University of Washington?
University of Washington is located at 325 9TH AVE, SEATTLE, WA 98104-2420. Use the Google Maps link in the intro above to get directions.
How do I contact University of Washington?
You can reach University of Washington by phone at (206) 744-4371. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.